Ashton Thomas Private Wealth’s Plus Therapeutics PSTV Stock Holding History
Bought
Maintained
Sold
Other funds holding PSTV
Ashton Thomas Private Wealth's PSTV Position: Q2 2026 in Review
Ashton Thomas Private Wealth increased its Plus Therapeutics (PSTV) stake by 2,505% in Q2 2026, buying an estimated $180K and bringing the position to 34,306 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #1203.
Ashton Thomas Private Wealth first reported a position in PSTV in Q2 2022 and has held it in 9 quarters since. 4 funds tracked by Wall St. Rank hold PSTV as of Q2 2026.
- Ashton Thomas Private Wealth held 34,306 shares of Plus Therapeutics worth $150K as of Q2 2026.
- Ashton Thomas Private Wealth bought 32,989 Plus Therapeutics shares in Q2 2026, an estimated $180K.
- Plus Therapeutics made up ﹤0.01% of Ashton Thomas Private Wealth's portfolio in Q2 2026, its #1203 holding.
- Ashton Thomas Private Wealth first reported a position in Plus Therapeutics in Q2 2022 and has held it in 9 quarters since.
- 4 funds tracked by Wall St. Rank held Plus Therapeutics as of Q2 2026.
Based on Ashton Thomas Private Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.